Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Mid Penn Bancorp, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Mid Penn Bancorp May 12, 202693.0%
-
Mid Penn Bancorp May 9, 202390.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 1, 2026 | Mid Penn Bancorp | Grant or award | +1,700 | — | — |
| May 8, 2025 | Mid Penn Bancorp | Open-market sale | −500 | $28.83 | $14,415 |
| Apr 1, 2025 | Mid Penn Bancorp | Grant or award | +1,945 | — | — |
| Sep 30, 2024 | Mid Penn Bancorp | Open-market purchase | +168 | $29.83 | $5,011 |
| Jun 28, 2024 | Mid Penn Bancorp | Open-market purchase | +227 | $21.95 | $4,983 |
| Apr 1, 2024 | Mid Penn Bancorp | Grant or award | +999 | — | — |
| Mar 28, 2024 | Mid Penn Bancorp | Open-market purchase | +250 | $20.01 | $5,003 |
| Dec 29, 2023 | Mid Penn Bancorp | Open-market purchase | +206 | $24.28 | $5,002 |
| Sep 29, 2023 | Mid Penn Bancorp | Open-market purchase | +248 | $20.13 | $4,992 |
| Jun 30, 2023 | Mid Penn Bancorp | Open-market purchase | +227 | $22.08 | $5,012 |
| Jun 1, 2023 | Mid Penn Bancorp | Grant or award | +1,760 | — | — |
| Mar 31, 2023 | Mid Penn Bancorp | Open-market purchase | +195 | $25.61 | $4,994 |
| Dec 30, 2022 | Mid Penn Bancorp | Open-market purchase | +167 | $29.97 | $5,005 |
Questions about Brian Arden Hudson Sr.
What boards is Brian Arden Hudson Sr. on?
Brian Arden Hudson Sr. sits on the boards of Erie Indemnity Company and Mid Penn Bancorp.
How long has Brian Arden Hudson Sr. served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.